iBio announced development of proprietary COVID-19 vaccine candidates
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
Edmonton company Entos Pharma developing DNA vaccine against COVID-19
On Mar. 18, 2020, Entos Pharmaceuticals announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections….
Oxford scientists developed rapid testing technology for COVID-19
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
Abbott received FDA Emergency Use Authorization and launched test to detect novel Coronavirus
On Mar. 18, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the company’s…
Mateon to develop its OT-101, a phase 3 clinical drug candidate against COVID-19
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…
Leading Stanford alumni scientists and physicians launched StartX Med COVID-19 task force
On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…
Eli Lilly and Indiana State Department of Health partnered to accelerate COVID-19 testing using Lilly Research Laboratories
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…
Emergent Biosolutions signed development and manufacturing agreement with Vaxart for experimental Coronavirus oral vaccine
On Mar. 18, 2020, Emergent BioSolutions announced an agreement with Vaxart, whereby Emergent has agreed to utilize its…
Nike leaders donated $7 million to support OHSU’s COVID-19 response
On Mar. 18, 2020, Nike CEO John Donahoe and his wife, Eileen, along with Nike Chairman Mark Parker…
Research revealed new coronavirus stable for hours on surfaces
On Mar. 17, 2020, the virus that causes coronavirus disease 2019 (COVID-19) was stable for several hours to…
Getinge increased production capacity of ventilators with 60% to support the needs of global ICU’s
On Mar. 17, 2020, Getinge has since the outbreak of the COVID-19 pandemic seen an increased global demand…
Monkeys developed protective antibodies to SARS-CoV-2
On Mar. 17, 2020, a small study of macaques found they don’t develop a coronavirus infection the second…
CanSinoBIO’s investigational vaccine against COVID-19 approved for phase 1 clinical trial in China
On Mar. 17, 2020, CanSino Biologics announced that its recombinant novel Coronavirus Vaccine (Adenovirus Type 5 Vector) candidate…
Israel weighed “compassionate use” of Pluristem therapy for COVID-19
On Mar. 17, 2020, Israel’s Health Ministry announced that it had approved a request by Pluristem Therapeutics to…
Quidel received Emergency Use Authorization for molecular COVID-19 diagnostic assay
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
MannKind refocuses pipeline resources in response to COVID-19 pandemic
On Mar. 17, 2020, MannKind announced it is adjusting research and development resources that were reserved for its…
Genomic analysis showed COVID-19 coronavirus epidemic has a natural origin
On Mar. 17, 2020, scientists reported the novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China,…
Innovation Pharmaceuticals Brilacidin tested as drug and vaccine at different institutions
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
Latest FDA guidance allows distribution of SARS-CoV-2 serology tests for diagnostic use
On Mar. 17, 2020, BioMedomics announced it will be able to distribute their COVID-19 IgM-IgG Antibody Rapid Test…
BioReference Laboratories and NYC Health + Hospitals announced collaboration to provide Coronavirus testing
On Mar. 17, 2020, BioReference Laboratories, an OPKO Health company, announced a collaboration with the New York City…
Pfizer and BioNTech co-develop potential Coronavirus (COVID-19)
On Mar. 17, 2020, Pfizer and BioNTech SE announced the companies have agreed to a letter of intent…
Regeneron announced important advances in novel COVID-19 antibody program
On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…
NIH clinical trial of investigational vaccine for COVID-19 began in Seattle
On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…
Hologic’s molecular test for the novel Coronavirus, SARS-CoV-2, receives FDA Emergency Use Authorization
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
BD, BioGX announced FDA Emergency Use Authorization submissions for new COVID-19 diagnostics for use in U.S.
On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…
Sanofi and Regeneron began global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19
On Mar. 16, 2020, Sanofi and Regeneron Pharma announced they have started a clinical program evaluating Kevzara (sarilumab)…
Meridian Bioscience supports companies in fighting Coronavirus withg zero cost proprietary technology for evaluation
On Mar. 16, 2020, Meridian Bioscience announced today its increased commitment to the global fight against COVID-19 by…
PathGroup launched testing for Coronavirus Disease 2019 (COVID-19)
On Mar. 16, 2020, PathGroup announced it had begun to offer testing for Coronavirus Disease 2019 (COVID-19). This…
NIH Reported First Known Employee with COVID-19 Infection
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
Fosun Pharma and BioNTech formed COVID-19 vaccine strategic alliance in China
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…